Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women

Journal of the National Cancer Institute

Volumn 95, Issue 14, 2003, Pages 1062-1071

  Strickler, Howard D ^a   Palefsky, Joel M ^b   Shah, Keerti V ^c   Anastos, Kathryn ^d   Klein, Robert S ^a   Minkoff, Howard ^e   Duerr, Ann ^f   Massad, L Steward ^g   Celentano, David D ^c   Hall, Charles ^a   Fazzari, Melissa ^a   Cu Uvin, Susan ^h   Bacon, Melanie ⁱ   Schuman, Paula ^j   Levine, Alexandra M ^k   Durante, Amanda J ^a   Gange, Stephen ^c   Melnick, Sandra ^l   Burk, Robert D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d LINCOLN MEDICAL AND MENTAL HEALTH CENTER   (United States)

^e MAIMONIDES MEDICAL CENTER   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h BROWN UNIVERSITY   (United States)

ⁱ GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^j WAYNE STATE UNIVERSITY   (United States)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^l NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CLINICAL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; IMMUNOSURVEILLANCE; INCIDENCE; LAVAGE; LYMPHOCYTE COUNT; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SERODIAGNOSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS; ADOLESCENT; ADULT; AGED; AIDS RELATED COMPLEX; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; DNA PROBE; FOLLOW UP; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PAPILLOMA VIRUS; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; DNA PROBES, HPV; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; LYMPHOCYTE COUNT; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; TUMOR VIRUS INFECTIONS;

EID: 0042767642     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/95.14.1062     Document Type: Article

References (29)

1. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
2. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-37.
3. Rattray C, Strickler HD, Escoffery C, Cranston B, Brown C, Manns A, et al. Type-specific prevalence of human papillomavirus DNA among Jamaican colposcopy patients. J Infect Dis 1996;173:718-21.
4. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
5. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999;91:226-36.
6. Feingold AR, Vermund SH, Burk RD, Kelley KF, Schrager LK, Schreiber K, et al. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1990;3:896-903.
7. Laga M, Icenogle JP, Marsella R, Manoka AT, Nzila N, Ryder RW, et al. Genital papillomavirus infection and cervical dysplasia-opportunistic complications of HIV infection. Int J Cancer 1992;50:45-8.
8. Sun XW, Ellerbrock TV, Lungu O, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet Gynecol 1995;85:680-6.
9. Ho GY, Burk RD, Fleming I, Klein RS. Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer 1994;56:788-92.
10. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998;9:117-25.
11. Hessol NA, Schneider M, Greenblatt RM, Bacon M, Barranday Y, Holman S, et al. Retention of women enrolled in a prospective study of human immunodeficiency virus infection: impact of race, unstable housing, and use of human immunodeficiency virus therapy. Am J Epidemiol 2001;154: 563-73.
12. Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, et al. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr 1999;21:33-41.
13. Smith DK, Warren DL, Vlahov D, Schuman P, Stein MD, Greenberg BL, et al. Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol 1997;146:459-69.
14. Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, et al. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 2001;184:682-90.
15. Duerr A, Kieke B, Warren D, Shah K, Burk R, Peipert JF, et al. Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. Am J Obstet Gynecol 2001;184:584-90.
16. Daniel RW, Ahdieh L, Hayden D, Cu-Uvin S, Shah KV. Intra-laboratory reproducibility of human papillomavirus identification in cervical specimens by a polymerase chain reaction-based assay. J Clin Virol 2000;19: 187-93.
17. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
18. Tachezy R, Van Ranst MA, Cruz Y, Burk RD. Analysis of short novel human papillomavirus sequences. Biochem Biophys Res Commun 1994; 204:820-7.
19. Jiang G, Qu W, Ruan H, Burk RD. Elimination of false-positive signals in enhanced chemiluminescence (ECL) detection of amplified HPV DNA from clinical samples. Biotechniques 1995;19:566-8.
20. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
21. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 1997;35:1304-10.
22. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998; 36:3020-7.
23. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988;44:1049-60.
24. Altman DG, De Stavola BL. Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates. Stat Med 1994;13:301-41.
25. Hougaard P. Frailty models for survival data. Lifetime Data Anal 1995;1: 255-73.
26. Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modelling marginal distributions. J. Am Stat Assoc 1989;84:1065-73.
27. Strickler H, Hoover DR, Dersimonian R. Problems in interpreting HIV sentinel seroprevalence studies. Ann Epidemiol 1995;5:447-54.
28. Liaw KL, Glass AG, Manos MM, Greer CE, Scott DR, Sherman M, et al. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst 1999;91:954-60.
29. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000;92:1500-10.